The Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ): Turkish adaptation, validity, and reliability study
Authors:
Preprint
- 5 April 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose The patient-reported outcome becomes important to evaluate the situation perceived by the patients and to develop new strategies. This study aims to adapt the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ), which was specially developed for patients with acromegaly, into Turkish by conducting a validity and reliability study. Methods After the translation and back-translation process, Acro-TSQ was filled in by face-to-face interviews with 136 patients diagnosed with acromegaly and currently receiving somatostatin analogue injection therapy. Internal consistency, content validity, construct validity, and reliability of the scale were determined. Results Acro-TSQ had a six-factor structure and explained 77.2% of the total variance in the variable. The Cronbach alpha value calculated for internal reliability showed high internal consistency (Cronbach's alpha = 0.870). Factor loads of all items were found to be between 0.567 and 0.958. As a result of EFA analysis, one item fell into a different factor in the Turkish version of the Acro-TSQ, different from its original form. CFA analysis shows that acceptable fit values are obtained for fit indices. Conclusion The Acro-TSQ, a patient-reported outcome tool, shows good internal consistency, and good reliability, suggesting it is an appropriate assessment tool for patients with acromegaly in the Turkish populationKeywords
All Related Versions
- Version 1, 2023-04-05, Research Square
- Published version: Pituitary, 26 (4), 429.
This publication has 14 references indexed in Scilit:
- A Pituitary Society update to acromegaly management guidelinesPituitary, 2020
- Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practiceBMC Endocrine Disorders, 2020
- Cognitive-behavioral therapy improves the quality of life of patients with acromegalyPituitary, 2018
- Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegalyPituitary, 2017
- Epidemiology of acromegaly: review of population studiesPituitary, 2016
- SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot studyPituitary, 2015
- Impact of treatment satisfaction on quality of life of patients with acromegalyPituitary, 2013
- Determining the number of factors to retain in an exploratory factor analysis using comparison data of known factorial structure.Psychological Assessment, 2012
- Medical Therapy of AcromegalyDrugs, 2009
- Quality of Life in Patients with a Pituitary AdenomaPituitary, 2003